Get the composition of our in-house portfolios

All portfolios and performance
Portfolio Ref: EQ3520LO2W
Performance in the last:
Follow this Portfolio
1D 3.2 %
1W 5.4 %
2W 9.5 %
1M 12.7 %
3M 12.2 %
6M 19.5 %
9M 28.1 %
1Y 29.4 %
Alpha
20.1%
Beta
0.49
sharpe-R
1.81
Benchmark
SP500 (SPDR S&P 500 ETF Trust)
sharpe-R Benchmark
3.03
The portfolio metrics Alpha, Beta and Sharpe Ratio are computed using a risk free rate of 0%.
Other Information
Calculation Frequency Daily
Latest Valuation Time 2024-11-08 07:57:28
Launch Date 2023-01-01 00:00:00
First Valuation Date 2021-01-01 00:00:00
Max. DrawDown -10.53%
Max. DrawDown Benchmark -8.41%

This Long Only strategy aims to find promising assets to invest in for a maximum holding period of 2 Weeks in the Equity asset class. This portfolio focuses only on companies in the Health Care sector. The maximum number of assets that can be allocated in this strategy is 20.

The assets selection in this portfolio is based on: Macro-Pattern Mix St..
Please note that all model portfolios assume that the entry price for each trade is the previous close price.

Portfolio Performance against the market Benchmark

Try Our Peformance Checker Tool

Risk Level
2
Difficulty Level
2

Do you want to invest in this strategy ?

Follow the portfolio and you will get notified for every change in the composition of the portfolio

Current Portfolio Composition

Asset Asset Class Action Weight PnL
HCSG Healthcare Services Group, Inc. Equity Buy 5.15% 7.31%
IOVA Iovance Biotherapeutics, Inc. Equity Buy 5.34% 11.33%
NEOG Neogen Corporation Equity Buy 5.18% 10.04%
INCY Incyte Corporation Equity Buy 5.19% 11.38%
ATEC Alphatec Holdings, Inc. Equity Buy 5.53% 19.87%
AVXL Anavex Life Sciences Corp. Equity Buy 5.32% 15.33%
MCRB Seres Therapeutics, Inc. Equity Buy 4.03% -12.8%
ORMP Oramed Pharmaceuticals Inc. Equity Buy 4.62% 0%
MGNX MacroGenics, Inc. Equity Buy 5.32% 15.25%
IRTC iRhythm Technologies, Inc. Equity Buy 4.87% 8.99%
CORT Corcept Therapeutics Incorporated Equity Buy 4.85% 8.47%
IART Integra LifeSciences Holdings Corporation Equity Buy 4.57% 2.41%
AVNS Avanos Medical, Inc. Equity Buy 4.61% 3.29%
LGND Ligand Pharmaceuticals Incorporated Equity Buy 5.21% 16.89%
ORGO Organogenesis Holdings Inc. Equity Buy 4.78% 7.24%
HUM Humana Inc. Equity Buy 4.48% -0.26%
AMN AMN Healthcare Services, Inc. Equity Buy 4.46% -0.68%
CARA Cara Therapeutics, Inc. Equity Buy 4.83% 0%
SAGE Sage Therapeutics, Inc. Equity Buy 4.83% 0%
CHRS Coherus BioSciences, Inc. Equity Buy 4.83% 0%
The percentage of cash held in the portfolio is: 2%
** The description of each asset is available Here

The latest 5 Compositions change

2024-11-08 00:00:00 : Portfolio change date
Asset Action Weight PnL
HCSG Healthcare Services Group, Inc. Buy 5.15% 7.31%
IOVA Iovance Biotherapeutics, Inc. Buy 5.34% 11.33%
NEOG Neogen Corporation Buy 5.18% 10.04%
INCY Incyte Corporation Buy 5.19% 11.38%
ATEC Alphatec Holdings, Inc. Buy 5.53% 19.87%
AVXL Anavex Life Sciences Corp. Buy 5.32% 15.33%
MCRB Seres Therapeutics, Inc. Buy 4.03% -12.8%
ORMP Oramed Pharmaceuticals Inc. Buy 4.62% 0%
MGNX MacroGenics, Inc. Buy 5.32% 15.25%
IRTC iRhythm Technologies, Inc. Buy 4.87% 8.99%
CORT Corcept Therapeutics Incorporated Buy 4.85% 8.47%
IART Integra LifeSciences Holdings Corporation Buy 4.57% 2.41%
AVNS Avanos Medical, Inc. Buy 4.61% 3.29%
LGND Ligand Pharmaceuticals Incorporated Buy 5.21% 16.89%
ORGO Organogenesis Holdings Inc. Buy 4.78% 7.24%
HUM Humana Inc. Buy 4.48% -0.26%
AMN AMN Healthcare Services, Inc. Buy 4.46% -0.68%
CARA Cara Therapeutics, Inc. Buy 4.83% 0%
SAGE Sage Therapeutics, Inc. Buy 4.83% 0%
CHRS Coherus BioSciences, Inc. Buy 4.83% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • CARA
  • SAGE
  • CHRS
Assets Removed
Asset Action Perf %
NVRO Sell All -1.11%
QDEL Sell All -0.61%
IBRX Sell All 25.89%
Assets Rebalanced
None
2024-11-07 00:00:00 : Portfolio change date
Asset Action Weight PnL
IBRX ImmunityBio, Inc. Buy 5.58% 28.74%
HCSG Healthcare Services Group, Inc. Buy 5.21% 8.49%
IOVA Iovance Biotherapeutics, Inc. Buy 5.29% 10.06%
NEOG Neogen Corporation Buy 5.13% 8.93%
NVRO Nevro Corp. Buy 4.99% 7.04%
INCY Incyte Corporation Buy 5.1% 9.5%
ATEC Alphatec Holdings, Inc. Buy 5.22% 12.99%
AVXL Anavex Life Sciences Corp. Buy 5.44% 17.67%
MCRB Seres Therapeutics, Inc. Buy 4.25% -7.93%
ORMP Oramed Pharmaceuticals Inc. Buy 4.54% -1.68%
MGNX MacroGenics, Inc. Buy 5% 8.27%
IRTC iRhythm Technologies, Inc. Buy 4.91% 9.9%
CORT Corcept Therapeutics Incorporated Buy 4.84% 8.33%
QDEL QuidelOrtho Corporation Buy 4.57% 2.23%
IART Integra LifeSciences Holdings Corporation Buy 4.79% 7.19%
AVNS Avanos Medical, Inc. Buy 4.73% 5.92%
LGND Ligand Pharmaceuticals Incorporated Buy 4.7% 5.19%
ORGO Organogenesis Holdings Inc. Buy 4.71% 5.59%
HUM Humana Inc. Buy 4.5% 0%
AMN AMN Healthcare Services, Inc. Buy 4.5% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • HUM
  • AMN
Assets Removed
Asset Action Perf %
CDMO Sell All 5.98%
Assets Rebalanced
None
2024-11-06 00:00:00 : Portfolio change date
Asset Action Weight PnL
CDMO Avid Bioservices, Inc. Buy 4.55% 1.74%
IBRX ImmunityBio, Inc. Buy 5.78% 29.22%
HCSG Healthcare Services Group, Inc. Buy 5.15% 4.02%
IOVA Iovance Biotherapeutics, Inc. Buy 5.24% 5.71%
NEOG Neogen Corporation Buy 5.09% 4.74%
NVRO Nevro Corp. Buy 4.95% 2.96%
INCY Incyte Corporation Buy 5.02% 4.53%
ATEC Alphatec Holdings, Inc. Buy 5.21% 9.3%
AVXL Anavex Life Sciences Corp. Buy 5.54% 16.31%
MCRB Seres Therapeutics, Inc. Buy 4.72% -0.98%
ORMP Oramed Pharmaceuticals Inc. Buy 4.71% -1.26%
MGNX MacroGenics, Inc. Buy 4.64% -2.58%
IRTC iRhythm Technologies, Inc. Buy 4.91% 6.43%
CORT Corcept Therapeutics Incorporated Buy 4.8% 4.16%
QDEL QuidelOrtho Corporation Buy 4.66% 1.13%
IART Integra LifeSciences Holdings Corporation Buy 4.61% 0%
AVNS Avanos Medical, Inc. Buy 4.61% 0%
LGND Ligand Pharmaceuticals Incorporated Buy 4.61% 0%
ORGO Organogenesis Holdings Inc. Buy 4.61% 0%
The percentage of cash held in the portfolio is: 6.61%
New Assets Added
  • IART
  • AVNS
  • LGND
  • ORGO
Assets Removed
Asset Action Perf %
NUTX Sell All 0.73%
PTCT Sell All 3.94%
Assets Rebalanced
None
2024-11-05 00:00:00 : Portfolio change date
Asset Action Weight PnL
NUTX Nutex Health Inc. Buy 4.29% -7.17%
PTCT PTC Therapeutics, Inc. Buy 4.75% 2.72%
CDMO Avid Bioservices, Inc. Buy 4.57% -0.19%
IBRX ImmunityBio, Inc. Buy 5.66% 23.52%
HCSG Healthcare Services Group, Inc. Buy 5.18% 2.01%
IOVA Iovance Biotherapeutics, Inc. Buy 5.27% 3.72%
NEOG Neogen Corporation Buy 5.01% 0.63%
NVRO Nevro Corp. Buy 4.88% -0.93%
INCY Incyte Corporation Buy 5.05% 2.46%
ATEC Alphatec Holdings, Inc. Buy 5.2% 6.5%
AVXL Anavex Life Sciences Corp. Buy 5.39% 10.27%
MCRB Seres Therapeutics, Inc. Buy 4.81% -1.59%
ORMP Oramed Pharmaceuticals Inc. Buy 4.91% 0.42%
MGNX MacroGenics, Inc. Buy 4.67% -4.39%
IRTC iRhythm Technologies, Inc. Buy 4.73% 0%
CORT Corcept Therapeutics Incorporated Buy 4.73% 0%
QDEL QuidelOrtho Corporation Buy 4.73% 0%
The percentage of cash held in the portfolio is: 16.18%
New Assets Added
  • IRTC
  • CORT
  • QDEL
Assets Removed
Asset Action Perf %
VKTX Sell All -13.77%
Assets Rebalanced
None
2024-11-04 00:00:00 : Portfolio change date
Asset Action Weight PnL
NUTX Nutex Health Inc. Buy 4.2% -8.94%
PTCT PTC Therapeutics, Inc. Buy 4.75% 2.92%
CDMO Avid Bioservices, Inc. Buy 4.53% -0.87%
VKTX Viking Therapeutics, Inc. Buy 4.55% -0.46%
IBRX ImmunityBio, Inc. Buy 5.73% 25.42%
HCSG Healthcare Services Group, Inc. Buy 5.16% 1.83%
IOVA Iovance Biotherapeutics, Inc. Buy 5.14% 1.45%
NEOG Neogen Corporation Buy 5% 0.7%
NVRO Nevro Corp. Buy 5.03% 2.41%
INCY Incyte Corporation Buy 5.06% 2.98%
ATEC Alphatec Holdings, Inc. Buy 5.03% 3.31%
AVXL Anavex Life Sciences Corp. Buy 5.03% 3.25%
MCRB Seres Therapeutics, Inc. Buy 4.88% 0.24%
ORMP Oramed Pharmaceuticals Inc. Buy 4.75% -2.52%
MGNX MacroGenics, Inc. Buy 4.87% 0%
The percentage of cash held in the portfolio is: 26.33%
New Assets Added
  • MGNX
Assets Removed
None
Assets Rebalanced
None
2024-11-01 00:00:00 : Portfolio change date
Asset Action Weight PnL
NUTX Nutex Health Inc. Buy 4.19% -10.19%
PTCT PTC Therapeutics, Inc. Buy 4.74% 1.53%
CDMO Avid Bioservices, Inc. Buy 4.44% -3.86%
VKTX Viking Therapeutics, Inc. Buy 4.58% -0.93%
IBRX ImmunityBio, Inc. Buy 5.72% 23.75%
HCSG Healthcare Services Group, Inc. Buy 5.13% 0.18%
IOVA Iovance Biotherapeutics, Inc. Buy 4.85% -5.35%
NEOG Neogen Corporation Buy 5% -0.42%
NVRO Nevro Corp. Buy 5.07% 2.04%
INCY Incyte Corporation Buy 4.98% 0.26%
ATEC Alphatec Holdings, Inc. Buy 4.93% 0%
AVXL Anavex Life Sciences Corp. Buy 4.93% 0%
MCRB Seres Therapeutics, Inc. Buy 4.93% 0%
ORMP Oramed Pharmaceuticals Inc. Buy 4.93% 0%
The percentage of cash held in the portfolio is: 31.57%
New Assets Added
  • ATEC
  • AVXL
  • MCRB
  • ORMP
Assets Removed
Asset Action Perf %
VREX Sell All 8.51%
AXSM Sell All -4.63%
Assets Rebalanced
None
2024-10-31 00:00:00 : Portfolio change date
Asset Action Weight PnL
VREX Varex Imaging Corporation Buy 5.08% 10.33%
AXSM Axsome Therapeutics, Inc. Buy 4.41% -4.17%
NUTX Nutex Health Inc. Buy 4.37% -5.16%
PTCT PTC Therapeutics, Inc. Buy 4.77% 3.41%
CDMO Avid Bioservices, Inc. Buy 4.47% -2.03%
VKTX Viking Therapeutics, Inc. Buy 4.48% -2.01%
IBRX ImmunityBio, Inc. Buy 6.12% 33.97%
HCSG Healthcare Services Group, Inc. Buy 5.11% 0.91%
IOVA Iovance Biotherapeutics, Inc. Buy 5.07% 0.09%
NEOG Neogen Corporation Buy 5.04% 1.6%
NVRO Nevro Corp. Buy 4.91% 0%
INCY Incyte Corporation Buy 4.91% 0%
The percentage of cash held in the portfolio is: 41.27%
New Assets Added
  • NVRO
  • INCY
Assets Removed
Asset Action Perf %
ALGN Sell All -2.57%
Assets Rebalanced
None
2024-10-30 00:00:00 : Portfolio change date
Asset Action Weight PnL
VREX Varex Imaging Corporation Buy 5.07% 10%
AXSM Axsome Therapeutics, Inc. Buy 4.46% -3.21%
NUTX Nutex Health Inc. Buy 4.11% -10.96%
PTCT PTC Therapeutics, Inc. Buy 4.99% 8.09%
CDMO Avid Bioservices, Inc. Buy 4.49% -1.74%
ALGN Align Technology, Inc. Buy 4.49% -1.68%
VKTX Viking Therapeutics, Inc. Buy 4.58% 0.18%
IBRX ImmunityBio, Inc. Buy 6.09% 33.25%
HCSG Healthcare Services Group, Inc. Buy 5.1% 0.64%
IOVA Iovance Biotherapeutics, Inc. Buy 4.97% -1.99%
NEOG Neogen Corporation Buy 4.97% 0%
The percentage of cash held in the portfolio is: 46.69%
New Assets Added
  • NEOG
Assets Removed
Asset Action Perf %
NKTR Sell All -12.41%
Assets Rebalanced
None
2024-10-29 00:00:00 : Portfolio change date
Asset Action Weight PnL
VREX Varex Imaging Corporation Buy 4.95% 8.68%
NKTR Nektar Therapeutics Buy 4.27% -6.21%
AXSM Axsome Therapeutics, Inc. Buy 4.4% -3.47%
NUTX Nutex Health Inc. Buy 4.41% -3.3%
PTCT PTC Therapeutics, Inc. Buy 4.7% 2.95%
CDMO Avid Bioservices, Inc. Buy 4.41% -2.51%
ALGN Align Technology, Inc. Buy 4.51% -0.29%
VKTX Viking Therapeutics, Inc. Buy 4.6% 1.78%
IBRX ImmunityBio, Inc. Buy 6.63% 46.56%
HCSG Healthcare Services Group, Inc. Buy 5.01% 0%
IOVA Iovance Biotherapeutics, Inc. Buy 5.01% 0%
The percentage of cash held in the portfolio is: 47.1%
New Assets Added
  • HCSG
  • IOVA
Assets Removed
Asset Action Perf %
ARWR Sell All 4.24%
VCEL Sell All 8.48%
SGMO Sell All 110.31%
Assets Rebalanced
None
2024-10-28 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARWR Arrowhead Pharmaceuticals, Inc. Buy 4.89% 3.82%
VCEL Vericel Corporation Buy 4.9% 3.94%
SGMO Sangamo Therapeutics, Inc. Buy 7.29% 54.64%
VREX Varex Imaging Corporation Buy 5.04% 6.69%
NKTR Nektar Therapeutics Buy 4.3% -8.97%
AXSM Axsome Therapeutics, Inc. Buy 4.55% -3.73%
NUTX Nutex Health Inc. Buy 4.63% -2.14%
PTCT PTC Therapeutics, Inc. Buy 4.91% 3.64%
CDMO Avid Bioservices, Inc. Buy 4.52% -3.47%
ALGN Align Technology, Inc. Buy 4.75% 1.33%
VKTX Viking Therapeutics, Inc. Buy 5% 6.57%
IBRX ImmunityBio, Inc. Buy 5.92% 26.37%
The percentage of cash held in the portfolio is: 39.29%
New Assets Added
None
Assets Removed
Asset Action Perf %
ARDX Sell All -4.47%
Assets Rebalanced
None
2024-10-25 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 4.64% -2.98%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 4.93% 2.94%
VCEL Vericel Corporation Buy 4.87% 1.85%
SGMO Sangamo Therapeutics, Inc. Buy 7.35% 53.61%
VREX Varex Imaging Corporation Buy 5.08% 5.95%
NKTR Nektar Therapeutics Buy 4.46% -6.9%
AXSM Axsome Therapeutics, Inc. Buy 4.56% -4.84%
NUTX Nutex Health Inc. Buy 4.76% -0.97%
PTCT PTC Therapeutics, Inc. Buy 5.06% 5.29%
CDMO Avid Bioservices, Inc. Buy 4.69% -1.45%
ALGN Align Technology, Inc. Buy 4.76% 0%
VKTX Viking Therapeutics, Inc. Buy 4.76% 0%
IBRX ImmunityBio, Inc. Buy 4.76% 0%
The percentage of cash held in the portfolio is: 35.31%
New Assets Added
  • ALGN
  • VKTX
  • IBRX
Assets Removed
None
Assets Rebalanced
None
2024-10-24 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 4.41% -7.62%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 4.91% 2.89%
VCEL Vericel Corporation Buy 4.79% 0.45%
SGMO Sangamo Therapeutics, Inc. Buy 7.57% 58.76%
VREX Varex Imaging Corporation Buy 5.04% 5.37%
NKTR Nektar Therapeutics Buy 4.65% -2.76%
AXSM Axsome Therapeutics, Inc. Buy 4.73% -1.1%
NUTX Nutex Health Inc. Buy 4.56% -4.88%
PTCT PTC Therapeutics, Inc. Buy 5.17% 8.04%
CDMO Avid Bioservices, Inc. Buy 4.74% 0%
The percentage of cash held in the portfolio is: 49.43%
New Assets Added
  • CDMO
Assets Removed
Asset Action Perf %
CDXS Sell All -9.73%
Assets Rebalanced
None
2024-10-23 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 4.62% -4.3%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 5.08% 5.27%
VCEL Vericel Corporation Buy 4.8% -0.62%
CDXS Codexis, Inc. Buy 4.7% -2.65%
SGMO Sangamo Therapeutics, Inc. Buy 6.02% 24.74%
VREX Varex Imaging Corporation Buy 5.01% 3.64%
NKTR Nektar Therapeutics Buy 4.8% -0.69%
AXSM Axsome Therapeutics, Inc. Buy 4.79% -1.02%
NUTX Nutex Health Inc. Buy 4.85% 0%
PTCT PTC Therapeutics, Inc. Buy 4.85% 0%
The percentage of cash held in the portfolio is: 50.48%
New Assets Added
  • NUTX
  • PTCT
Assets Removed
Asset Action Perf %
LXRX Sell All -3.48%
Assets Rebalanced
None
2024-10-22 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 4.78% -2.65%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 5.2% 5.84%
VCEL Vericel Corporation Buy 4.8% -2.16%
CDXS Codexis, Inc. Buy 4.76% -2.95%
SGMO Sangamo Therapeutics, Inc. Buy 4.6% -6.19%
VREX Varex Imaging Corporation Buy 5.12% 4.13%
NKTR Nektar Therapeutics Buy 4.71% -4.14%
LXRX Lexicon Pharmaceuticals, Inc. Buy 4.77% -2.99%
AXSM Axsome Therapeutics, Inc. Buy 4.82% -1.98%
The percentage of cash held in the portfolio is: 56.43%
New Assets Added
None
Assets Removed
Asset Action Perf %
BKD Sell All 3.8%
Assets Rebalanced
None
2024-10-21 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 4.7% -3.31%
BKD Brookdale Senior Living Inc. Buy 5.28% 8.76%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 5.31% 9.4%
VCEL Vericel Corporation Buy 4.81% -1.02%
CDXS Codexis, Inc. Buy 4.89% 0.59%
SGMO Sangamo Therapeutics, Inc. Buy 4.61% -5.08%
VREX Varex Imaging Corporation Buy 4.97% 2.07%
NKTR Nektar Therapeutics Buy 4.73% -2.76%
LXRX Lexicon Pharmaceuticals, Inc. Buy 5.04% 3.48%
AXSM Axsome Therapeutics, Inc. Buy 4.87% 0%
The percentage of cash held in the portfolio is: 50.8%
New Assets Added
None
Assets Removed
Asset Action Perf %
ORGO Sell All 2.6%
Assets Rebalanced
None
2024-10-18 00:00:00 : Portfolio change date
Asset Action Weight PnL
ORGO Organogenesis Holdings Inc. Buy 4.88% -0.32%
ARDX Ardelyx, Inc. Buy 4.71% -3.48%
BKD Brookdale Senior Living Inc. Buy 5.33% 9.26%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 5.25% 7.64%
VCEL Vericel Corporation Buy 4.71% -3.37%
CDXS Codexis, Inc. Buy 4.85% -0.59%
SGMO Sangamo Therapeutics, Inc. Buy 4.73% -3.09%
VREX Varex Imaging Corporation Buy 4.89% 0%
NKTR Nektar Therapeutics Buy 4.89% 0%
LXRX Lexicon Pharmaceuticals, Inc. Buy 4.89% 0%
AXSM Axsome Therapeutics, Inc. Buy 4.89% 0%
The percentage of cash held in the portfolio is: 45.99%
New Assets Added
  • VREX
  • NKTR
  • LXRX
  • AXSM
Assets Removed
Asset Action Perf %
RDNT Sell All -3.2%
Assets Rebalanced
None
2024-10-17 00:00:00 : Portfolio change date
Asset Action Weight PnL
ORGO Organogenesis Holdings Inc. Buy 5.11% 5.52%
ARDX Ardelyx, Inc. Buy 4.67% -3.15%
BKD Brookdale Senior Living Inc. Buy 5.33% 10.41%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 5.26% 8.99%
VCEL Vericel Corporation Buy 4.73% -1.95%
RDNT RadNet, Inc. Buy 4.81% -0.34%
CDXS Codexis, Inc. Buy 5.01% 3.83%
SGMO Sangamo Therapeutics, Inc. Buy 4.93% 2.27%
The percentage of cash held in the portfolio is: 60.15%
New Assets Added
None
Assets Removed
Asset Action Perf %
IRWD Sell All 5.63%
Assets Rebalanced
None
2024-10-16 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 5.04% 3.05%
ORGO Organogenesis Holdings Inc. Buy 5.08% 3.9%
ARDX Ardelyx, Inc. Buy 4.82% -1.16%
BKD Brookdale Senior Living Inc. Buy 4.89% 0.33%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 5.01% 2.69%
VCEL Vericel Corporation Buy 4.86% -0.33%
RDNT RadNet, Inc. Buy 4.89% 0.2%
CDXS Codexis, Inc. Buy 4.88% 0%
SGMO Sangamo Therapeutics, Inc. Buy 4.88% 0%
The percentage of cash held in the portfolio is: 55.65%
New Assets Added
  • CDXS
  • SGMO
Assets Removed
None
Assets Rebalanced
None
2024-10-15 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 4.95% 0.7%
ORGO Organogenesis Holdings Inc. Buy 4.93% 0.32%
ARDX Ardelyx, Inc. Buy 4.86% -0.83%
BKD Brookdale Senior Living Inc. Buy 4.9% 0%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 4.9% 0%
VCEL Vericel Corporation Buy 4.9% 0%
RDNT RadNet, Inc. Buy 4.9% 0%
The percentage of cash held in the portfolio is: 65.67%
New Assets Added
  • BKD
  • ARWR
  • VCEL
  • RDNT
Assets Removed
None
Assets Rebalanced
None
2024-10-14 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 4.92% 0%
ORGO Organogenesis Holdings Inc. Buy 4.9% -0.32%
ARDX Ardelyx, Inc. Buy 4.9% 0%
The percentage of cash held in the portfolio is: 85.29%
New Assets Added
  • ARDX
Assets Removed
None
Assets Rebalanced
None
2024-10-11 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 4.86% -1.17%
ORGO Organogenesis Holdings Inc. Buy 4.83% -1.95%
The percentage of cash held in the portfolio is: 90.31%
New Assets Added
None
Assets Removed
Asset Action Perf %
BCRX Sell All -6.07%
Assets Rebalanced
None
2024-10-07 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 4.94% 0.94%
BCRX BioCryst Pharmaceuticals, Inc. Buy 4.9% 0%
ORGO Organogenesis Holdings Inc. Buy 4.9% 0%
The percentage of cash held in the portfolio is: 85.26%
New Assets Added
  • BCRX
  • ORGO
Assets Removed
None
Assets Rebalanced
None
2024-10-03 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 4.9% 0%
The percentage of cash held in the portfolio is: 95.1%
New Assets Added
  • IRWD
Assets Removed
None
Assets Rebalanced
None
2024-09-23 00:00:00 : Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is: 100%
New Assets Added
None
Assets Removed
Asset Action Perf %
MYGN Sell All 2.48%
Assets Rebalanced
None
2024-09-20 00:00:00 : Portfolio change date
Asset Action Weight PnL
MYGN Myriad Genetics, Inc. Buy 4.91% 4.89%
The percentage of cash held in the portfolio is: 95.09%
New Assets Added
None
Assets Removed
Asset Action Perf %
NVCR Sell All -1.16%
Assets Rebalanced
None
2024-09-17 00:00:00 : Portfolio change date
Asset Action Weight PnL
NVCR NovoCure Limited Buy 4.66% -0.5%
MYGN Myriad Genetics, Inc. Buy 4.85% 3.45%
The percentage of cash held in the portfolio is: 90.49%
New Assets Added
None
Assets Removed
Asset Action Perf %
TVTX Sell All 48.65%
Assets Rebalanced
None
2024-09-16 00:00:00 : Portfolio change date
Asset Action Weight PnL
TVTX Travere Therapeutics, Inc. Buy 6.77% 40.42%
NVCR NovoCure Limited Buy 4.83% 2.88%
MYGN Myriad Genetics, Inc. Buy 4.81% 2.3%
The percentage of cash held in the portfolio is: 83.58%
New Assets Added
None
Assets Removed
Asset Action Perf %
MGNX Sell All 5.41%
ESPR Sell All 4.37%
Assets Rebalanced
None
2024-09-12 00:00:00 : Portfolio change date
Asset Action Weight PnL
MGNX MacroGenics, Inc. Buy 5.15% 3.13%
ESPR Esperion Therapeutics, Inc. Buy 4.75% -4.92%
TVTX Travere Therapeutics, Inc. Buy 6.26% 27.5%
NVCR NovoCure Limited Buy 4.57% -4.54%
MYGN Myriad Genetics, Inc. Buy 4.66% -2.56%
The percentage of cash held in the portfolio is: 74.61%
New Assets Added
None
Assets Removed
Asset Action Perf %
PODD Sell All 11.4%
Assets Rebalanced
None
2024-09-10 00:00:00 : Portfolio change date
Asset Action Weight PnL
PODD Insulet Corporation Buy 5.37% 7.2%
MGNX MacroGenics, Inc. Buy 4.92% -1.71%
ESPR Esperion Therapeutics, Inc. Buy 4.65% -7.1%
TVTX Travere Therapeutics, Inc. Buy 6.59% 33.96%
NVCR NovoCure Limited Buy 4.41% -7.98%
MYGN Myriad Genetics, Inc. Buy 4.83% 0.63%
The percentage of cash held in the portfolio is: 69.22%
New Assets Added
None
Assets Removed
Asset Action Perf %
ALDX Sell All -6.49%
AADI Sell All 3.43%
Assets Rebalanced
None
2024-09-09 00:00:00 : Portfolio change date
Asset Action Weight PnL
AADI Aadi Bioscience, Inc. Buy 5.3% 4.57%
PODD Insulet Corporation Buy 5.33% 5.05%
MGNX MacroGenics, Inc. Buy 4.69% -7.41%
ESPR Esperion Therapeutics, Inc. Buy 4.57% -9.84%
TVTX Travere Therapeutics, Inc. Buy 5.7% 14.37%
ALDX Aldeyra Therapeutics, Inc. Buy 4.74% -3.01%
NVCR NovoCure Limited Buy 4.54% -6.48%
MYGN Myriad Genetics, Inc. Buy 4.86% 0%
The percentage of cash held in the portfolio is: 60.27%
New Assets Added
  • MYGN
Assets Removed
None
Assets Rebalanced
None
2024-09-06 00:00:00 : Portfolio change date
Asset Action Weight PnL
AADI Aadi Bioscience, Inc. Buy 5.2% 2.86%
PODD Insulet Corporation Buy 5.35% 5.72%
MGNX MacroGenics, Inc. Buy 4.87% -3.7%
ESPR Esperion Therapeutics, Inc. Buy 4.75% -6.01%
TVTX Travere Therapeutics, Inc. Buy 5.14% 3.44%
ALDX Aldeyra Therapeutics, Inc. Buy 4.87% 0%
NVCR NovoCure Limited Buy 4.84% 0%
The percentage of cash held in the portfolio is: 64.97%
New Assets Added
  • NVCR
Assets Removed
Asset Action Perf %
CARA Sell All -6.41%
AGEN Sell All -8.59%
Assets Rebalanced
None

Load more previous compositions

Compositions In The Last 2W Compositions In The Last 1M Compositions In The Last 3M Compositions In The Last 6M

Market Overview

Disclaimer Quantam Research does not provide personal investment or financial advice to individuals, or act as personal financial, legal, or institutional investment advisors, or individually advocate the purchase or sale of any security or investment or the use of any particular financial strategy. All investing, assets forecasts and investment strategies include the risk of loss for some or even all of your capital. Before pursuing any financial strategies discussed on this website, you should always consult with a licensed financial advisor.
Cookies Settings